Cardiovascular Information System Market is Projected to Reach $2.49 Billion by 2034 with a 7.4% CAGR | Fact.MR Report

January 17, 2025 11:45 PM AEDT | By EIN Presswire
 Cardiovascular Information System Market is Projected to Reach $2.49 Billion by 2034 with a 7.4% CAGR | Fact.MR Report
Image source: EIN Presswire

Rising Number of Patients Worldwide with Cardiovascular Illnesses Driving Demand for Cardiovascular Information Systems ROCKVILLE, MD, UNITED STATES, January 17, 2025 /EINPresswire.com/ -- The global cardiovascular information system market, estimated at US$ 1.21 billion for 2024, is projected to expand at a CAGR of 7.4% from 2024 to 2034. Factors such as high acceptance rates and rising awareness of these systems' benefits contribute to market growth.

Cardiovascular treatment is becoming more and more complicated, requiring sophisticated systems like electronic health records (EHRs) to manage massive volumes of data, retrieve data, and keep patient history records, among other things. Growing demand for cardiovascular devices is primarily driven by the rising number of patients with cardiovascular illnesses and disorders worldwide as well as the increased need for efficient data management solutions in cardiac care units.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9741

CVIS is a groundbreaking instrument that improves cardiac patient care efficiency. The technology enables enhanced workflow management, precise diagnostic capabilities, and patient safety by combining enormous volumes of data in real-time. When taken as a whole, these elements help doctors make well-informed treatment choices. Furthermore, the market generates lucrative opportunities for players given the growing remote medical data accessibility and the move toward zero-footprint systems.

Key Takeaways from Market Study

The global cardiovascular information system market is estimated at US$ 1.21 billion in 2024. Demand for cardiovascular information systems is projected to rise at a CAGR of 7.4% from 2024 to 2034.

The market is projected to reach US$ 2.49 billion by 2034-end. North America is estimated to account for 41.5% share of the market by 2034. The hardware segment is projected to expand at a CAGR of 7% from 2024 to 2034.

The market in North America is forecasted to expand at a CAGR of 7.7% through 2034. The market in East Asia is projected to expand at a CAGR of 7% from 2024 to 2034.

“Need for cardiovascular information systems has increased as a result of ongoing technological advancements. A significant cause for concern has been the rise in chronic cardiovascular disease prevalence in developing countries in recent years. Due to the widespread prevalence of cardiovascular disease (CVD), there is a substantial volume of data associated with it, making manual handling challenging. By using cardiovascular information systems, healthcare providers may identify patients more precisely and manage patient data more effectively,” says a Fact.MR analyst.

Leading Players Driving Innovation in the Cardiovascular Information System Market:

Philips Healthcare; GE Healthcare; Cisco Systems; Fujifilm Medical Systems, Inc.; Siemens Healthcare GmbH; Cerner Corporation; LUMEDX Corporation

Improved Effectiveness and Interoperability of Diagnostic Centers

Rising prevalence of cardiovascular illnesses and the expanding medical industry are major factors propelling the market's expansion. Globally, the number of individuals experiencing cardiac failures, ischemic heart disease (IHD), and arrhythmias is on the rise due to the aging population and sedentary lifestyle choices.

The market is growing at a fast pace due to the adoption of digitalization and advancements in the healthcare information technology (IT) industry. The technology is being used by healthcare organizations to remotely access medical records and photographs, which improves the effectiveness and interoperability of diagnostic centers.

In February 2023, the Cardiovascular Institute of the South (CIS), an independent cardiovascular practitioner in the United States, teamed up with Lee Equity Partners, a private equity firm based in New York City, to launch Cardiovascular Logistics, a national platform for cardiovascular care.
Cardiovascular Information Systems Industry News:

For example, Philips introduced IntelliSpace Cardiovascular 4.1, the next-generation cardiovascular image and information management system, in February 2019. This solution provides a holistic perspective to help you make more educated decisions while improving the patient and staff experience, improving health outcomes, and lowering healthcare costs. This allows the organization to broaden its presence globally.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9741

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the cardiovascular information system market for 2018 to 2023 and forecast statistics for 2024 to 2034.

The study divulges essential insights into the market based on component (hardware, software, services), deployment (cloud-based, on-premise), application (catheterization, echocardiography, electrocardiogram, electrophysiology), and end user (hospitals, clinics, cardiac cath labs, ambulatory surgical centers, diagnostic centers), across six major regions of the world (North America, Latin America, Europe, East Asia, South Asia & Oceania, and MEA).

Explore More Related Studies Published by Fact.MR Research:

The global peptide-based cardiovascular therapeutics market is valued at US$ 2.2 billion in 2023 and is predicted to reach US$ 4.1 billion by 2033-end. Global demand for peptide-based cardiovascular therapeutics is forecasted to increase at a CAGR of 6.4% from 2023 to 2033.

The global cardiovascular disease monitoring and diagnostic devices market is projected to rise at a CAGR of 6% from 2022 to 2027. The market is expected to secure a market value of around US$ 4.2 billion by 2027, up from US$ 3.14 billion in 2022.

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay competitive.

Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: [email protected]
Follow Us: LinkedIn | Twitter | Blog

S. N. Jha
Fact.MR
+ +1 628-251-1583
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.